Exogenous C3 postpones complement exhaustion and confers organ protection in murine sepsis

Journal of Surgical Research

Volumn 168, Issue 1, 2011, Pages

  Yuan, Yujie ^a   Ren, Jianan ^a   Wu, Xiuwen ^a   Cao, Shougen ^a   Li, Jieshou ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

C3; colon ascendens stent peritonitis; complement system; inflammatory cytokines; sepsis

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; INTERLEUKIN 10; PHOSPHATE BUFFERED SALINE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL SURGERY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; COLON ASCENDENS STENT PERITONITIS SURGERY; COLONY FORMING UNIT; COMPLEMENT ACTIVATION; COMPLEMENT FACTOR; CONTROLLED STUDY; CYTOKINE RELEASE; ESCHERICHIA COLI; FEMALE; INFLAMMATION; MOUSE; NONHUMAN; ORGAN INJURY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPSIS; SURGICAL MORTALITY; SURGICAL RISK;

ANIMALS; COMPLEMENT C3; COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; PERITONITIS; SEPSIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955589527     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.01.062     Document Type: Article

References (20)

1. Lambris JD, Ricklin D, Geisbrecht BV. Complement evasion by human pathogens. Nat Rev Microbiol 2008;6:132.
2. Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res 2010;20:34.
3. Daha MR, van Kooten C, Roos A. Compliments from complement: A fourth pathway of complement activation? Nephrol Dial Transplant 2006;21:3374.
4. Stove S, Welte T, Wagner TO, et al. Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome. Clin Diagn Lab Immunol 1996;3:175.
5. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699.
6. Lindenauer PK, Rothberg MB, Nathanson BH, et al. Activated protein C and hospital mortality in septic shock: A propensity-matched analysis. Crit Care Med 2010;38:1101.
7. Goring K, Huang Y, Mowat C, et al. Mechanisms of human complement factor B induction in sepsis and inhibition by activated protein C. Am J Physiol Cell Physiol 2009;296:C1140.
8. Zantl N, Uebe A, Neumann B, et al. Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun 1998;66:2300.
9. Dinis-Oliveira RJ, Duarte JA, Remiao F, et al. Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats. Toxicology 2006;227:73.
10. Maier S, Traeger T, Entleutner M, et al. Cecal ligation and puncture versus colon ascendens stent peritonitis: Two distinct animal models for polymicrobial sepsis. Shock 2004;21:505.
11. Kiank C, Koerner P, Kessler W, et al. Seasonal variations in inflammatory responses to sepsis and stress in mice. Crit Care Med 2007;35:2352.
12. Lam C, Schulz F, Laber G, et al. Opsonic activity of the alternative complement pathway in infected human intra-abdominal fluid. Infection 1985;13:8.
13. Holers VM, Thurman JM. The alternative pathway of complement in disease: Opportunities for therapeutic targeting. Mol Immunol 2004;41:147.
14. Moreno-Navarrete JM, Martinez-Barricarte R, Catalan V, et al. Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes 2010;59:200.
15. Fakhouri F, de Jorge EG, Brune F, et al. Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice. Kidney Int 2010;78:279.
16. Wessels MR, Butko P, Ma M, et al. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A 1995;92:11490.
17. Fischer MB, Prodeus AP, Nicholson-Weller A, et al. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J Immunol 1997;159:976.
18. Barrington R, Zhang M, Fischer M, et al. The role of complement in inflammation and adaptive immunity. Immunol Rev 2001;180:5.
19. Prodeus AP, Zhou X, Maurer M, et al. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997;390:172.
20. Yalcindag A, He R, Laouini D, et al. The complement component C3 plays a critical role in both Th1 and Th2 responses to antigen. J Allergy Clin Immunol 2006;117:1455.